Alcon Competitors

Alcon (NYSE:ALC) and HCA Healthcare (NYSE:HCA) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings and risk.

Insider and Institutional Ownership

46.5% of Alcon shares are owned by institutional investors. Comparatively, 68.7% of HCA Healthcare shares are owned by institutional investors. 1.5% of Alcon shares are owned by company insiders. Comparatively, 1.8% of HCA Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Alcon and HCA Healthcare's net margins, return on equity and return on assets.

Risk and Volatility

Alcon has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, HCA Healthcare has a beta of 1.58, meaning that its stock price is 58% more volatile than the S&P 500.

Valuation and Earnings

This table compares Alcon and HCA Healthcare's revenue, earnings per share (EPS) and valuation.

HCA Healthcare has higher revenue and earnings than Alcon. HCA Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Alcon and HCA Healthcare, as reported by MarketBeat.com.

Alcon currently has a consensus target price of $65.80, indicating a potential downside of 6.84%. HCA Healthcare has a consensus target price of $171.9375, indicating a potential downside of 2.47%. Given HCA Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe HCA Healthcare is more favorable than Alcon.

Summary

HCA Healthcare beats Alcon on 13 of the 14 factors compared between the two stocks.

Alcon (NYSE:ALC) and Universal Health Services (NYSE:UHS) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Alcon and Universal Health Services' net margins, return on equity and return on assets.

Risk & Volatility

Alcon has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Universal Health Services has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500.

Earnings & Valuation

This table compares Alcon and Universal Health Services' gross revenue, earnings per share (EPS) and valuation.

Universal Health Services has higher revenue and earnings than Alcon. Universal Health Services is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

46.5% of Alcon shares are owned by institutional investors. Comparatively, 82.3% of Universal Health Services shares are owned by institutional investors. 1.5% of Alcon shares are owned by company insiders. Comparatively, 12.6% of Universal Health Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Alcon and Universal Health Services, as provided by MarketBeat.com.

Alcon currently has a consensus price target of $65.80, suggesting a potential downside of 6.84%. Universal Health Services has a consensus price target of $138.70, suggesting a potential upside of 7.70%. Given Universal Health Services' stronger consensus rating and higher possible upside, analysts clearly believe Universal Health Services is more favorable than Alcon.

Summary

Universal Health Services beats Alcon on 12 of the 14 factors compared between the two stocks.

Tenet Healthcare (NYSE:THC) and Alcon (NYSE:ALC) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.

Analyst Ratings

This is a summary of current ratings and price targets for Tenet Healthcare and Alcon, as reported by MarketBeat.

Tenet Healthcare currently has a consensus target price of $43.8824, suggesting a potential downside of 17.36%. Alcon has a consensus target price of $65.80, suggesting a potential downside of 6.84%. Given Alcon's higher probable upside, analysts clearly believe Alcon is more favorable than Tenet Healthcare.

Volatility & Risk

Tenet Healthcare has a beta of 2.66, meaning that its stock price is 166% more volatile than the S&P 500. Comparatively, Alcon has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500.

Insider & Institutional Ownership

93.1% of Tenet Healthcare shares are held by institutional investors. Comparatively, 46.5% of Alcon shares are held by institutional investors. 1.7% of Tenet Healthcare shares are held by insiders. Comparatively, 1.5% of Alcon shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Tenet Healthcare and Alcon's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Tenet Healthcare and Alcon's top-line revenue, earnings per share (EPS) and valuation.

Tenet Healthcare has higher revenue and earnings than Alcon. Tenet Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Summary

Tenet Healthcare beats Alcon on 10 of the 14 factors compared between the two stocks.

Alcon (NYSE:ALC) and Acadia Healthcare (NASDAQ:ACHC) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and profitability.

Valuation and Earnings

This table compares Alcon and Acadia Healthcare's top-line revenue, earnings per share and valuation.

Acadia Healthcare has lower revenue, but higher earnings than Alcon. Acadia Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Alcon and Acadia Healthcare, as provided by MarketBeat.com.

Alcon currently has a consensus price target of $65.80, indicating a potential downside of 6.84%. Acadia Healthcare has a consensus price target of $48.2222, indicating a potential downside of 14.65%. Given Alcon's higher probable upside, research analysts clearly believe Alcon is more favorable than Acadia Healthcare.

Institutional & Insider Ownership

46.5% of Alcon shares are held by institutional investors. 1.5% of Alcon shares are held by insiders. Comparatively, 1.6% of Acadia Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Alcon and Acadia Healthcare's net margins, return on equity and return on assets.

Volatility & Risk

Alcon has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Comparatively, Acadia Healthcare has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500.

Summary

Acadia Healthcare beats Alcon on 10 of the 15 factors compared between the two stocks.

The Ensign Group (NASDAQ:ENSG) and Alcon (NYSE:ALC) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Valuation and Earnings

This table compares The Ensign Group and Alcon's top-line revenue, earnings per share (EPS) and valuation.

The Ensign Group has higher earnings, but lower revenue than Alcon. Alcon is trading at a lower price-to-earnings ratio than The Ensign Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares The Ensign Group and Alcon's net margins, return on equity and return on assets.

Risk & Volatility

The Ensign Group has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. Comparatively, Alcon has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and target prices for The Ensign Group and Alcon, as reported by MarketBeat.com.

The Ensign Group currently has a consensus target price of $63.80, indicating a potential downside of 23.23%. Alcon has a consensus target price of $65.80, indicating a potential downside of 6.84%. Given Alcon's higher probable upside, analysts clearly believe Alcon is more favorable than The Ensign Group.

Insider & Institutional Ownership

78.6% of The Ensign Group shares are owned by institutional investors. Comparatively, 46.5% of Alcon shares are owned by institutional investors. 6.8% of The Ensign Group shares are owned by insiders. Comparatively, 1.5% of Alcon shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

The Ensign Group beats Alcon on 10 of the 14 factors compared between the two stocks.

Select Medical (NYSE:SEM) and Alcon (NYSE:ALC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, institutional ownership, profitability and earnings.

Valuation and Earnings

This table compares Select Medical and Alcon's revenue, earnings per share and valuation.

Select Medical has higher earnings, but lower revenue than Alcon. Select Medical is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations for Select Medical and Alcon, as provided by MarketBeat.

Select Medical presently has a consensus target price of $29.8333, indicating a potential downside of 10.17%. Alcon has a consensus target price of $65.80, indicating a potential downside of 6.84%. Given Alcon's higher probable upside, analysts plainly believe Alcon is more favorable than Select Medical.

Risk and Volatility

Select Medical has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Alcon has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500.

Insider & Institutional Ownership

74.4% of Select Medical shares are held by institutional investors. Comparatively, 46.5% of Alcon shares are held by institutional investors. 19.7% of Select Medical shares are held by insiders. Comparatively, 1.5% of Alcon shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Select Medical and Alcon's net margins, return on equity and return on assets.

Summary

Select Medical beats Alcon on 9 of the 14 factors compared between the two stocks.